BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37551918)

  • 41. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer.
    Shin JY; Yoon JK; Marwaha G
    Lung; 2018 Jun; 196(3):351-358. PubMed ID: 29550987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer.
    Moore KA; Mery CM; Jaklitsch MT; Estocin AP; Bueno R; Swanson SJ; Sugarbaker DJ; Lukanich JM
    Ann Thorac Surg; 2003 Dec; 76(6):1789-95. PubMed ID: 14667585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group.
    Ostheimer C; Mäurer M; Ebert N; Schmitt D; Krug D; Baumann R; Henkenberens C; Giordano FA; Sautter L; López G; Fleischmann DF; Niyazi M; Käsmann L; Kaul D; Thieme AH; Billiet C; Dobiasch S; Arnold CR; Oertel M; Haussmann J; Gauer T; Goy Y; Suess C; Ziegler S; Panje CM; Baues C; Trommer M; Skripcak T; Medenwald D
    Strahlenther Onkol; 2021 May; 197(5):385-395. PubMed ID: 33410959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older.
    Driessen E; Detillon D; Bootsma G; De Ruysscher D; Veen E; Aarts M; Janssen-Heijnen M
    J Geriatr Oncol; 2019 Jul; 10(4):547-554. PubMed ID: 30876833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not.
    Brule SY; Al-Baimani K; Jonker H; Zhang T; Nicholas G; Goss G; Laurie SA; Wheatley-Price P
    Lung Cancer; 2016 Jul; 97():15-21. PubMed ID: 27237022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.
    von Verschuer U; Schnell R; Tessen HW; Eggert J; Binninger A; Spring L; Jänicke M; Marschner N;
    Lung Cancer; 2017 Oct; 112():216-224. PubMed ID: 28916198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 49. Statins use and its impact in EGFR-TKIs resistance to prolong the survival of lung cancer patients: A Cancer registry cohort study in Taiwan.
    Nguyen PA; Chang CC; Galvin CJ; Wang YC; An SY; Huang CW; Wang YH; Hsu MH; Li YJ; Yang HC
    Cancer Sci; 2020 Aug; 111(8):2965-2973. PubMed ID: 32441434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
    Chi A; Fang W; Sun Y; Wen S
    JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of Preoperative FDG PET/CT and Survival of Patients with Resectable Non-Small Cell Lung Cancer.
    Chen WM; Chen M; Hsu JG; Lee TS; Shia BC; Wu SY
    Radiology; 2022 Oct; 305(1):219-227. PubMed ID: 35727156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Matter of Comprehensive Informed Consent: Short-Term Mortality Rates With Definitive Treatment Options in Elderly Stage I NSCLC.
    Dalwadi SM; Savjani RR; Bernicker EH; Butler EB; Teh BS; Farach AM
    Am J Clin Oncol; 2019 Nov; 42(11):851-855. PubMed ID: 31573986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
    Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer.
    Shao YY; Shau WY; Lin ZZ; Chen HM; Kuo R; Yang JC; Lai MS
    Eur J Cancer; 2013 Jan; 49(1):106-14. PubMed ID: 22897841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan.
    Huang HL; Kung PT; Chiu CF; Wang YH; Tsai WC
    PLoS One; 2014; 9(7):e101731. PubMed ID: 24999633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
    PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
    Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
    Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment.
    Koul R; Rathod S; Dubey A; Bashir B; Chowdhury A
    Lung Cancer; 2018 Sep; 123():116-120. PubMed ID: 30089581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.